Viracta Therapeutics (Series B)
Funding Details
Awarder
Inbox
Date Award
April 4, 2017
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$18,400,000
Company Info
Founders
Ivor Royston, M. D.
Market
Viral-associated cancers and other serious diseases
Location
San Diego, California, USA
Coinvestors
Forward Ventures, Latterell Venture Partners, NantKwest, Wicklow Capital
Company Description

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Biotechnology DealsView Funding Announcement